Faculty Invitation & Financial Relationships Form
Controversies & Advances in the Treatment of Cardiovascular Disease: The Twenty-First in the Series
November 30 - December 1, 2023 • Beverly Hills, California
Enter your full name exactly as it should appear in the meeting materials.
Faculty includes speakers, moderators, planners, peer reviewers, and course directors.
Enter the email where you would like to receive future meeting correspondence.
Enter the degrees/credentials you would like to appear in the meeting materials.
Enter your affiliation to be listed in the meeting materials
If you would like us to include your assistant on meeting correspondence, please enter their email here.
As a prospective participant, we would like to ask for your help in protecting our learning environment from industry influence. Please complete the form below and click "Submit Form" when you reach the end.
The ACCME Standards for Integrity and Independence require that we disqualify individuals who refuse to provide this information from involvement in the planning and implementation of accredited continuing education. Thank you for your diligence and assistance. If you have questions, please contact us at [email protected].
Instructions for this form
1) Please disclose all financial relationships that you have had in the past 24 months with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. More information here.
2) For each financial relationship, enter the name of the ineligible company and the nature of the financial relationship(s ). There is no minimum financial threshold; we ask that you disclose all financial relationships, regardless of the amount, with ineligible companies. You should disclose all financial relationships regardless of the potential relevance of each relationship to the education.
Examples of financial relationships include employee, researcher, consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and ownership interest. Individual stocks and stock options should be disclosed; diversified mutual funds do not need to be disclosed. Research funding from ineligible companies should be
disclosed by the principal or named investigator even if that individual's institution receives the research grant and manages the funds.
3) If the financial relationship existed during the last 24 months, but has now ended, please indicate in the field provided. This will help the education staff determine if any
mitigation steps need to be taken.
To add additional relationships, click the plus button on the right-hand side.
MM slash DD slash YYYY
Please click "submit form" below to submit your decline to participate.